Mammary Carcinoma Update 2019 - A continuing education series from the MCI Academy 2019

Memo

Prof. Dr. med. Michael Untch would like to invite you to an interactive and up-to-date event in Berlin on the 10th of August. The individual treatment of patients with breast cancer has evolved in recent years. In addition to advanced therapy in the established subgroups (hormone receptor and HER2 status), there are now therapies based on single molecular characteristics, such as PARP inhibitor therapy in patients with BRCA mutations. In addition, tests are presented that predict the effectiveness of therapy within subgroups.We would like to introduce you to these innovations and discuss the implementation for our patients. We will take into account the current recommendations of the AGO Mamma and the latest results of the ASCO 2019. In addition, we will have enough time for case discussions in small groups and a personal exchange. We look forward to an exciting discussion with you! The Breast Cancer Breast Cancer 2019 is a brand new MCI Academy event series. From June to August 2019, 5 events will take place throughout Germany on the latest study results and therapy trends for breast cancer. In keynote speeches and ContentCamps a high practical relevance is conveyed and the discussion and active participation of the participants are promoted.The MCI Academy is the organizer of content-centered medical continuing education events that combine completely new types of event formats with innovative forms of interaction.URL: Tickets: https://go.evvnt.com/399720-2?pid=5569Artists / Speakers: Prof. Dr. med. Michael UntchSaturday August 10, 2019 at 9:00 am (ends Saturday August 10, 2019 at 3:00 pm)Venue details: Leonardo Royal Hotel Berlin Alexanderplatz, Otto-Braun-Strasse 90, Berlin 10249, Germany